Potency Assays for Measuring the Engraftment Potential of HSPCs
The transplantation of hematopoietic stem cells (HSCs) obtained from bone marrow (BM), mobilized peripheral blood (MPB) and umbilical cord blood (CB) has become an established therapy to regenerate the immuno-hematopoietic system in cancer patients following ablative chemo/radiotherapy and in patients with non-malignant hematological disorders. An important question in this field is how to measure the number of hematopoietic stem and progenitor cells (HSPCs) in a cellular product prior to its infusion. This information can be used to assist in graft selection and, ideally, to prospectively predict the likelihood of successful engraftment.
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to ϳԹ Canada Inc. and its subsidiaries and affiliates (“ϳԹ”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
